Four Decades for Justice
Nicole M. Peles has a broad litigation practice, with a particular focus on antitrust, including antitrust counseling, regulatory work and antitrust litigation.
Ms. Peles has represented clients on antitrust issues in connection with numerous proposed or completed deals. These representations include:
On the litigation front, Ms. Peles’s representative matters include:
Ms. Peles was born in Berkeley, California. She received an A.B. from Dartmouth College in 2007 and a J.D. cum laude from New York University in 2010, where she was an executive editor of the Law Review. After graduation, Ms. Peles served as a law clerk to Hon. Nancy F. Atlas of the U.S. District Court for the Southern District of Texas.
Ms. Peles is admitted to practice in the U.S. District Courts for the District of Columbia, Eastern District of New York and Southern District of New York. She is a member of the American Bar Association’s Antitrust Section.
Ms. Peles joined Cravath as a summer associate in 2009 and rejoined Cravath’s legal staff in 2011. Ms. Peles was elected of counsel in 2023.
Ms. Peles has represented clients on antitrust issues in connection with numerous proposed or completed deals. These representations include:
On the litigation front, Ms. Peles’s representative matters include:
Ms. Peles was born in Berkeley, California. She received an A.B. from Dartmouth College in 2007 and a J.D. cum laude from New York University in 2010, where she was an executive editor of the Law Review. After graduation, Ms. Peles served as a law clerk to Hon. Nancy F. Atlas of the U.S. District Court for the Southern District of Texas.
Ms. Peles is admitted to practice in the U.S. District Courts for the District of Columbia, Eastern District of New York and Southern District of New York. She is a member of the American Bar Association’s Antitrust Section.
Ms. Peles joined Cravath as a summer associate in 2009 and rejoined Cravath’s legal staff in 2011. Ms. Peles was elected of counsel in 2023.
Deals & Cases
January 29, 2024
On January 29, 2024, Montana Technologies LLC (“Montana Technologies”) announced an agreement to form a joint venture with GE Vernova, a global leader in electrification, decarbonization, and energy solutions, to incorporate GE Vernova’s proprietary sorbent materials into systems that utilize Montana Technologies’ patented AirJoule® dehumidification, air conditioning, and atmospheric water harvesting technology. The joint venture will exclusively manufacture and supply products incorporating the combined technologies to leading original equipment manufacturers and customers in the Americas, Africa, and Australia. Cravath is representing Montana Technologies in connection with the transaction.
Deals & Cases
November 21, 2023
On November 21, 2023, Martin Marietta Materials, Inc. (“Martin Marietta”) announced that it has entered into a definitive agreement to sell its South Texas cement business and certain of its related concrete operations to CRH Americas Materials, Inc., a subsidiary of CRH plc, for $2.1 billion in cash. Cravath is representing Martin Marietta in connection with the transaction.
Deals & Cases
November 13, 2023
On November 9, 2023, Altus Group Limited (“Altus Group”), a leading provider of asset and fund intelligence for commercial restate, announced it has signed a definitive agreement to acquire the commercial real estate valuation and advisory services business of Situs Group LLC (a SitusAMC Company) for $225 million in cash. Cravath is representing Altus Group in connection with the transaction.
Deals & Cases
October 16, 2023
On October 16, 2023, Vista Outdoor Inc. (“Vista Outdoor”), the parent company of 41 renowned brands that design, manufacture and market sporting and outdoor products to consumers around the globe, announced a definitive agreement to sell its Sporting Products business to Czechoslovak Group a.s. (“CSG”), a leading industrial technology holding company, for an enterprise value of $1.91 billion in an all-cash transaction. This transaction represents the next step in Vista Outdoor’s plan to split the company into separate entities. Cravath is representing Vista Outdoor in connection with the transaction.
Deals & Cases
October 02, 2023
On October 1, 2023, Viatris Inc. (“Viatris”), a global healthcare company, announced it has received an offer for the divestiture of substantially all of its Over-the-Counter (“OTC”) business, and has entered into definitive agreements to divest its Women’s Healthcare business, its Active Pharmaceutical Ingredient (“API”) business in India and commercialization rights in certain non-core markets that were acquired as part of the combination with Upjohn. The total transactions value, including Viatris’s 2022 divestiture of its biosimilars business, represents up to $6.94 billion of total gross proceeds. The estimated transaction value for the divestitures announced today is $3.6 billion, including gross consideration of up to approximately $2.17 billion for the divestiture of substantially all of its OTC business, and up to approximately $1.2 billion combined for the divestitures of its API and Women’s Healthcare businesses. Cravath is representing Viatris in connection with the transactions.
Firm News
November 20, 2023
On November 17, 2023, Virginia M. Anderson, D. Ana Choi, Christopher P. Davis, Janice T.P. Martindale, Flora Ng, Nicole M. Peles, Scott B. Reents and Kathryn‑Ann Stamm were named of counsels of the Firm and Jean Kearns and DongHwa Kim were named senior attorneys of the Firm, effective January 1, 2024.
Activities & Publications
November 14, 2023
Cravath partner Margaret T. Segall authored a chapter entitled “Merger Remedies in Dynamic Industries” in Global Competition Review’s “Merger Remedies Guide – Fifth Edition,” which was published on October 25, 2023. The chapter, co‑authored by practice area attorney Nicole M. Peles, reviewed the common types of merger remedies, the characteristics of dynamic industries and challenges posed for traditional merger remedies. The chapter considered the different approaches adopted by antitrust authorities in creating remedies in the technology and pharmaceutical sectors, two rapidly evolving dynamic industries.
Nicole M. Peles has a broad litigation practice, with a particular focus on antitrust, including antitrust counseling, regulatory work and antitrust litigation.
Ms. Peles has represented clients on antitrust issues in connection with numerous proposed or completed deals. These representations include:
On the litigation front, Ms. Peles’s representative matters include:
Ms. Peles was born in Berkeley, California. She received an A.B. from Dartmouth College in 2007 and a J.D. cum laude from New York University in 2010, where she was an executive editor of the Law Review. After graduation, Ms. Peles served as a law clerk to Hon. Nancy F. Atlas of the U.S. District Court for the Southern District of Texas.
Ms. Peles is admitted to practice in the U.S. District Courts for the District of Columbia, Eastern District of New York and Southern District of New York. She is a member of the American Bar Association’s Antitrust Section.
Ms. Peles joined Cravath as a summer associate in 2009 and rejoined Cravath’s legal staff in 2011. Ms. Peles was elected of counsel in 2023.
Ms. Peles has represented clients on antitrust issues in connection with numerous proposed or completed deals. These representations include:
On the litigation front, Ms. Peles’s representative matters include:
Ms. Peles was born in Berkeley, California. She received an A.B. from Dartmouth College in 2007 and a J.D. cum laude from New York University in 2010, where she was an executive editor of the Law Review. After graduation, Ms. Peles served as a law clerk to Hon. Nancy F. Atlas of the U.S. District Court for the Southern District of Texas.
Ms. Peles is admitted to practice in the U.S. District Courts for the District of Columbia, Eastern District of New York and Southern District of New York. She is a member of the American Bar Association’s Antitrust Section.
Ms. Peles joined Cravath as a summer associate in 2009 and rejoined Cravath’s legal staff in 2011. Ms. Peles was elected of counsel in 2023.
Deals & Cases
January 29, 2024
On January 29, 2024, Montana Technologies LLC (“Montana Technologies”) announced an agreement to form a joint venture with GE Vernova, a global leader in electrification, decarbonization, and energy solutions, to incorporate GE Vernova’s proprietary sorbent materials into systems that utilize Montana Technologies’ patented AirJoule® dehumidification, air conditioning, and atmospheric water harvesting technology. The joint venture will exclusively manufacture and supply products incorporating the combined technologies to leading original equipment manufacturers and customers in the Americas, Africa, and Australia. Cravath is representing Montana Technologies in connection with the transaction.
Deals & Cases
November 21, 2023
On November 21, 2023, Martin Marietta Materials, Inc. (“Martin Marietta”) announced that it has entered into a definitive agreement to sell its South Texas cement business and certain of its related concrete operations to CRH Americas Materials, Inc., a subsidiary of CRH plc, for $2.1 billion in cash. Cravath is representing Martin Marietta in connection with the transaction.
Deals & Cases
November 13, 2023
On November 9, 2023, Altus Group Limited (“Altus Group”), a leading provider of asset and fund intelligence for commercial restate, announced it has signed a definitive agreement to acquire the commercial real estate valuation and advisory services business of Situs Group LLC (a SitusAMC Company) for $225 million in cash. Cravath is representing Altus Group in connection with the transaction.
Deals & Cases
October 16, 2023
On October 16, 2023, Vista Outdoor Inc. (“Vista Outdoor”), the parent company of 41 renowned brands that design, manufacture and market sporting and outdoor products to consumers around the globe, announced a definitive agreement to sell its Sporting Products business to Czechoslovak Group a.s. (“CSG”), a leading industrial technology holding company, for an enterprise value of $1.91 billion in an all-cash transaction. This transaction represents the next step in Vista Outdoor’s plan to split the company into separate entities. Cravath is representing Vista Outdoor in connection with the transaction.
Deals & Cases
October 02, 2023
On October 1, 2023, Viatris Inc. (“Viatris”), a global healthcare company, announced it has received an offer for the divestiture of substantially all of its Over-the-Counter (“OTC”) business, and has entered into definitive agreements to divest its Women’s Healthcare business, its Active Pharmaceutical Ingredient (“API”) business in India and commercialization rights in certain non-core markets that were acquired as part of the combination with Upjohn. The total transactions value, including Viatris’s 2022 divestiture of its biosimilars business, represents up to $6.94 billion of total gross proceeds. The estimated transaction value for the divestitures announced today is $3.6 billion, including gross consideration of up to approximately $2.17 billion for the divestiture of substantially all of its OTC business, and up to approximately $1.2 billion combined for the divestitures of its API and Women’s Healthcare businesses. Cravath is representing Viatris in connection with the transactions.
Firm News
November 20, 2023
On November 17, 2023, Virginia M. Anderson, D. Ana Choi, Christopher P. Davis, Janice T.P. Martindale, Flora Ng, Nicole M. Peles, Scott B. Reents and Kathryn‑Ann Stamm were named of counsels of the Firm and Jean Kearns and DongHwa Kim were named senior attorneys of the Firm, effective January 1, 2024.
Activities & Publications
November 14, 2023
Cravath partner Margaret T. Segall authored a chapter entitled “Merger Remedies in Dynamic Industries” in Global Competition Review’s “Merger Remedies Guide – Fifth Edition,” which was published on October 25, 2023. The chapter, co‑authored by practice area attorney Nicole M. Peles, reviewed the common types of merger remedies, the characteristics of dynamic industries and challenges posed for traditional merger remedies. The chapter considered the different approaches adopted by antitrust authorities in creating remedies in the technology and pharmaceutical sectors, two rapidly evolving dynamic industries.
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. ©2024 Cravath, Swaine & Moore LLP.